Titlebook: Chemotherapy Protocols and Infusion Sequence; Schedule Considerati Iago Dillion Lima Cavalcanti Book 2022 The Editor(s) (if applicable) and

condone

雀斑

協(xié)定

Brocas-Area

Polypharmacy in Cancer Therapy,ent of patients with multimorbidities and its use in the treatment of cancer patients. I also discuss drug interactions that can occur in patients using polypharmacy, highlighting studies that bring data on drug interactions in cancer treatment, such as pharmacodynamic and pharmacokinetic interactio

Deject

Combined Therapy for the Treatment of Cancer,ting the main drugs included in each anticancer therapy. In addition, I talk about combined therapy, which is based on the association of drugs with different mechanisms of action, promoting greater efficacy in cancer therapy, and I also highlight the main challenges of combined therapy, which shoul

整潔

Importance of the Infusion Order in the Treatment of Cancer, bring the classification of infusion types according to time, such as bolus infusion, rapid infusion and continuous infusion, and its purpose in the application of antineoplastic drugs. I discuss the differences between reconstitution and dilution of drugs, as well as their stability after reconsti

孤獨(dú)無助

Chemotherapeutic Protocols for the Treatment of Breast Cancer,e molecular subtype, and the main therapeutic modalities of breast cancer. I discuss several chemotherapy protocols used in the treatment of adjuvant breast cancer, such as the AC, ACT, CMF, FEC, DAC, TDC, and DCARBT protocols, among others. I also discuss the protocols indicated for the treatment o

車床

Chemotherapeutic Protocols for the Treatment of Gastrointestinal Tract Cancer,liary tract, gallbladder, liver, among others, addressing their epidemiological profiles, in addition to bringing some data about pathophysiology of each cancer. I also discuss the protocols used according to cancer of the gastrointestinal tract, bringing efficacy data for each protocol and their in

Basilar-Artery

Nucleate

Chemotherapeutic Protocols for the Treatment of Gynecological Cancer,ss the epidemiological profile of each cancer and bring some data on the pathophysiology, staging, and treatment modalities. The main chemotherapy protocols are also addressed, such as CABR, CAPBEV, CISP, CAD, EMA-CO, DM, among others. Administration schedules were based on clinical studies and prot